Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will ...
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...
Despite recent advances in screening and diagnosis, tuberculosis remains the deadliest infectious disease. An estimated 10·8 ...